Aptuit, Inc. has named Stuart E. Needleman senior director, API Development. Mr. Needleman brings more than 20 years experience in the global development, scale-up, and manufacture of regulated API for new and established compounds. He has been involved in projects for both small and large pharmaceutical companies, successfully matching API supply from discovery to post-launch commercial quantities. Mr. Needleman will lead the company’s charge to bring capabilities in API development to its customers and will focus on identifying acquisition opportunities at the API kilo laboratory and pilot plant scale.

Mr. Needleman has worked for Cambrex; Oxford Asymmetry, where he created a significant North American presence; ChiRex Inc. as vice president business development; Rhodia Pharma Solutions as general manager development operations and most recently as president, North America for Arch Pharmalabs with headquarters and manufacturing operations in India.